Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy

✍ Scribed by David G. Warr; James C. Street; Alexandra D. Carides

• Publisher: Springer-Verlag
• Year: 2010
• Tongue: English
• Weight: 152 KB
• Volume: 19
• Category: Article
• ISSN: 0941-4355
• DOI: 10.1007/s00520-010-0899-5